BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Microscopic Colitis readouts · AssetMemo
X-WR-CALDESC:Upcoming phase 1/2 and later readouts in Microscopic Colitis\,
  from ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07156175-11338@assetmemo.bio
DTSTAMP:20261121T004447Z
DTSTART;VALUE=DATE:20270408
DTEND;VALUE=DATE:20270409
SUMMARY:SAR444336: Phase 2 readout est. (NCT07156175)
DESCRIPTION:SAR444336\, phase 2\, Microscopic Colitis.\nStudy: A Study to I
 nvestigate the Efficacy and Safety of SAR444336 in Adults With Microscopic
  Colitis in Clinical Remission\nEstimated primary completion: 8 April 2027
 . This is a ClinicalTrials.gov estimate\, not a confirmed readout date\, a
 nd it can move.\nDrug page: https://assetmemo.bio/drug/sar444336#upcoming-
 events\nRegistry record: https://clinicaltrials.gov/study/NCT07156175
URL:https://assetmemo.bio/drug/sar444336#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
